The aim of this study was to investigate any difference of ultrasound findings for palpable and nonpalpable breast cancers. Methods: Two hundred breast cancer patients that had undergone preoperative ultrasound and surgery were enrolled in the study. A total of 126 cancers were palpable, and the remaining 74 cancers were nonpalpable. We compared lesion characteristics using ultrasound images according to the BI-RADS � � -Ultrasound guidelines of the American College of Radiology. A crude odds ratio (OR) and 95% confidence interval (CI) were calculated for a comparison of the palpable and nonpalpable breast cancers.
INTRODUCTION
Nonpalpable breast cancers have a better prognosis than palpable breast cancers, and a higher incidence of ductal carcinoma in situ (DCIS), a lower tumor stage, and a lower incidence of lymph node metastasis. (1) (2) (3) (4) (5) (6) (7) Currently, mammography has been used with clinical breast examination and breast self-examination for screening of breast cancer.
Mammography has been successfully used as a screening test for breast cancer over the past 20-30 yr, but has substantial limitations. Approximately 10-20% of palpable breast cancers are not visible on mammographic images, mainly due to insufficient contrast between normal and abnormal breast tissue. (8) (9) (10) Moreover, the sensitivity of mammography for the diagnosis of breast cancer is variable and known to be influenced by age, breast density, family history, and other factors. (11) False negative rates for mammographic breast cancer detection are higher in women with dense breast parenchyma, and the risks of subsequent breast cancer are also higher, particularly in women with a first-degree family history of breast cancer. (12) (13) (14) Breast ultrasound (US) is widely used as a supplementary modality for evaluating mammographically detected abnormalities, (15) (16) (17) and as an effective screening modality for detecting occult breast cancers in mammographically determined dense breasts. (15, (17) (18) (19) (20) (21) A study by Stavros et al.(22) reported that US has a high sensitivity and negative predictive value for diagnosing breast cancer, i.e., 98.4% and 99.5%, respectively, and recent advances in US technology and transducer design permit greater spatial and contrast resolution. Therefore, we decided to investigate the correlation between breast US and clinical findings in patients with breast cancer. Specifically, this study was undertaken to evaluate US findings in palpable and nonpalpable breast cancers and to identify US features that differentiate these two cancer groups. 
METHODS

Patients
Evaluation points
In our institute, US is routinely performed as an initial examination for palpable masses in women younger than 35 yr, and for nonpalpable masses detected by mammography, to allow mass characterization. US is also performed to screen women with mammographically dense breasts. One hundred ninety one patients in this study underwent breast US to further evaluate; abnormal mammographic findings (n=73), to screen mammographically dense breasts (n=47), and those with symptoms but without specific mammographic abnormalities (n=10), and as an initial examination in young women (n=61). Primary tumor (T stage), regional nodal status (N stage), and metastasis (M stage) were evaluated. Data were collected on paper and then entered into a customized database (Microsoft � Access 2.0; Microsoft, Redmond, USA).
Statistical analysis
To compare the clinical and US findings of palpable and nonpalpable breast cancers, the chi-squared homogeneity test and the student' s t-test were used, as appropriate. Statistical significance was considered if a p value was less than 0.05. A crude odds ratio (OR) and its 95% confidence interval (CI) were calculated for the presence of a palpable cancer based on each US finding.
All statistical analysis was performed using SAS version 9.12 (SAS Inc., Cary, USA). The statistical analysis of the data was supervised by a biostatistician. and orientation were significantly different between the two study groups (p<0.05). An "irregular"shape was more frequent for palpable cancers (98/126, 78% vs 40/ 74, 54%; OR=2.98, 95% CI=1.60-5.54) (Fig 1, 2) , whereas an "oval"shape was more common for nonpalpable cancers (24/74, 32% vs 18/126, 14%; OR=0.35, 95% CI=0.17-0.70) (Fig 3, 4) . In lesion margins, a "spiculated"margin was significantly more commonly observed in palpable cancers (37/126, 29% vs 10/74, 14%; OR=2.66, 95% CI= 1.23-5.74) (Fig 1) . With respect to posterior acoustic features, a "combined pattern"was more frequent for palpable cancers (21/126, 17% vs 2/74, 3%; OR=7.20, 95% CI=1.64-31.66) (Fig 1, 2) , whereas "no posterior acoustic features" was more common for nonpalpable cancers (44/ 74, 59% vs 53/126, 42%; OR=0.50, 95% CI=0.28-0.89) ( Fig 3) . A "not-parallel"orientation to skin was more common for palpable cancers (81/126, 64% vs 35/74, 47%; OR=2.01, 95% CI=1.12-3.60) (Fig 1, 2) and a "parallel"orientation was more common in nonpalpable cancers (39/74, 53% vs 45/126, 36%; OR=0.50, 95% CI=0.28-0.89) (Fig 3, 4 ). An "echogenic halo" (Fig 1, 2) and the "presence of microcalcifications"were more frequent in palpable than in nonpalpable cancers, but this was without significance (p>0.05).
RESULTS
DISCUSSION
The most important roles of US in breast imaging are; the characterization of masses that have been incompletely assessed by mammography, the characterization of palpable masses that are obscured by dense tissue during mammography, and screening for occult breast cancers in dense breasts by mammography. Breast US has been successfully used to differentiate benign and malignant breast lesions and to detect occult breast cancers in dense breasts. (15) (16) (17) (18) (19) (20) (21) (22) Our question was that breast US would correlate with clinical findings and prognosis.
There are a few reports to show correlation between tumor type or grade and US findings in breast cancers. In the present study, we evaluated differences between palpable and nonpalpable cancers in terms of their US characteristics; shape, margin, echo pattern, posterior acoustic features, orientation, lesion boundary, and presence of microcalcifications. Among these US characteristics, shape, margin, posterior acoustic feature, and orientation differed between the two study groups. An There are many reports to describe the usefulness of US in nonpalpable breast lesions for detection of malignancy and imaging-guided procedure. (15, (17) (18) (19) (20) (21) 28) However, there is no report to show that distinctive US findings for nonpalpable breast cancers when compared with palpable breast cancers. Our results demonstrated nonpalpable breast cancers had more often typical benign US findings; an "oval"shape, a "circumscribed"margin, "no posterior acoustic features" , a "parallel"orientation, and an "abrupt"interface. Among these findings, an "oval" shape, "no posterior acoustic features" , and a "parallel"orientation were significantly different between palpable and nonpalpable breast cancers. Therefore, physicians must consider these results before assessment of nonpalpable breast lesions on US and it may be necessary of more strict application of US criteria to nonpalpable breast lesions. If a nonpalpable lesion has a slight malignant feature on US, biopsy or aspiration should be considered.
The present study has several limitations. First, the study is limited by its retrospective nature. We included patients who underwent breast cancer surgery and breast US, and the total number of patients was small. Thus, a further prospective study in a larger population may be warranted. Second, the characteristics of palpable and nonpalpable cancers were compared by breast US, but these different US characteristics were not correlated with pathologic findings. Third, we included both invasive carcinomas and DCIS cases, thus, the study population was heterogeneous and it could produce biased results. In the 200 breast cancers, 167 were invasive carcinomas and 33 were DCIS cases. We hope further study would be performed in separate groups of histological tumor types.
CONCLUSION
In conclusion, the present study shows that the characteristics of palpable and nonpalpable cancers are quite different by breast US. Further study would be needed for investigation of the correlations between breast US findings and prognostic estimates in a large population.
